Your browser doesn't support javascript.
loading
An Aptamer against MNK1 for Non-Small Cell Lung Cancer Treatment.
Carrión-Marchante, Rebeca; Pinto-Díez, Celia; Klett-Mingo, José Ignacio; Palacios, Esther; Barragán-Usero, Miriam; Pérez-Morgado, M Isabel; Pascual-Mellado, Manuel; Alcalá, Sonia; Ruiz-Cañas, Laura; Sainz, Bruno; González, Víctor M; Martín, M Elena.
Afiliación
  • Carrión-Marchante R; Aptamer Group, Deparment Biochemistry-Research, IRYCIS-Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain.
  • Pinto-Díez C; Aptus Biotech SL, 28035 Madrid, Spain.
  • Klett-Mingo JI; Aptamer Group, Deparment Biochemistry-Research, IRYCIS-Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain.
  • Palacios E; Aptamer Group, Deparment Biochemistry-Research, IRYCIS-Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain.
  • Barragán-Usero M; Aptamer Group, Deparment Biochemistry-Research, IRYCIS-Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain.
  • Pérez-Morgado MI; Aptamer Group, Deparment Biochemistry-Research, IRYCIS-Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain.
  • Pascual-Mellado M; Aptamer Group, Deparment Biochemistry-Research, IRYCIS-Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain.
  • Alcalá S; Department of Cancer, Instituto de Investigaciones-Biomédicas "Alberto Sols" (IIBM), CSIC-UAM, 28034 Madrid, Spain.
  • Ruiz-Cañas L; Chronic Diseases and Cancer Area 3-Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain.
  • Sainz B; Department of Cancer, Instituto de Investigaciones-Biomédicas "Alberto Sols" (IIBM), CSIC-UAM, 28034 Madrid, Spain.
  • González VM; Chronic Diseases and Cancer Area 3-Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain.
  • Martín ME; Department of Cancer, Instituto de Investigaciones-Biomédicas "Alberto Sols" (IIBM), CSIC-UAM, 28034 Madrid, Spain.
Pharmaceutics ; 15(4)2023 Apr 18.
Article en En | MEDLINE | ID: mdl-37111758